These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11302407)

  • 1. Zolpidem for antipsychotic-induced parkinsonism.
    Farver DK; Khan MH
    Ann Pharmacother; 2001 Apr; 35(4):435-7. PubMed ID: 11302407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emerging role of clozapine in the treatment of movement disorders.
    Factor SA; Friedman JH
    Mov Disord; 1997 Jul; 12(4):483-96. PubMed ID: 9251065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zolpidem improves neuropsychiatric symptoms and motor dysfunction in a patient with Parkinson's disease after deep brain stimulation.
    Huang HY; Hsu YT; Wu YC; Chiou SM; Kao CH; Tsai MC; Tsai CH
    Acta Neurol Taiwan; 2012 Jun; 21(2):84-6. PubMed ID: 22879118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible anti-oxidant and neuroprotective mechanisms of zolpidem in attenuating typical anti-psychotic-induced orofacial dyskinesia: a biochemical and neurochemical study.
    Bishnoi M; Chopra K; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1130-8. PubMed ID: 17513028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quetiapine (Seroquel) in the treatment of psychosis in patients with Parkinson's disease.
    Parsa MA; Bastani B
    J Neuropsychiatry Clin Neurosci; 1998; 10(2):216-9. PubMed ID: 9608412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clozapine treatment of psychosis in patients with tardive dystonia: report of three cases.
    Friedman JH
    Mov Disord; 1994 May; 9(3):321-4. PubMed ID: 7913739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A hypnotic drug for sleep disturbances in patients with Parkinson's disease].
    Abe K; Hikita T; Sakoda S
    No To Shinkei; 2005 Apr; 57(4):301-5. PubMed ID: 15948402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological management of psychosis in elderly patients with parkinsonism.
    Hasnain M; Vieweg WV; Baron MS; Beatty-Brooks M; Fernandez A; Pandurangi AK
    Am J Med; 2009 Jul; 122(7):614-22. PubMed ID: 19559160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of tardive tremor successfully treated with clozapine.
    Delecluse F; Elosegi JA; Gérard JM
    Mov Disord; 1998 Sep; 13(5):846-7. PubMed ID: 9756158
    [No Abstract]   [Full Text] [Related]  

  • 10. A double-blind, comparative study of zolpidem and placebo in the treatment of insomnia in elderly psychiatric in-patients.
    Shaw SH; Curson H; Coquelin JP
    J Int Med Res; 1992 Apr; 20(2):150-61. PubMed ID: 1521671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor and non-motor features of Parkinson's disease that predict persistent drug-induced Parkinsonism.
    Morley JF; Pawlowski SM; Kesari A; Maina I; Pantelyat A; Duda JE
    Parkinsonism Relat Disord; 2014 Jul; 20(7):738-42. PubMed ID: 24742370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zolpidem-induced mania in a patient with schizoaffective disorder.
    Kinnan S; Petty F; Wilson DR
    Psychosomatics; 2011; 52(5):493-4. PubMed ID: 21907076
    [No Abstract]   [Full Text] [Related]  

  • 13. Rebound psychosis: effect of discontinuation of antipsychotics in Parkinson's disease.
    Fernandez HH; Trieschmann ME; Okun MS
    Mov Disord; 2005 Jan; 20(1):104-5. PubMed ID: 15390047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity, and treatment-resistant psychosis.
    Small JG; Milstein V; Marhenke JD; Hall DD; Kellams JJ
    J Clin Psychiatry; 1987 Jul; 48(7):263-7. PubMed ID: 2885310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversibility of long-term tardive dyskinesia associated with antiparkinsonian medication: a case report.
    Good MI
    Am J Psychiatry; 1981 Aug; 138(8):1112-3. PubMed ID: 6114643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential antipsychotic effects of zolpidem.
    Wong GY; Bastiampillai T; Dhillon R
    Aust N Z J Psychiatry; 2010 Feb; 44(2):190. PubMed ID: 20113310
    [No Abstract]   [Full Text] [Related]  

  • 17. [The role of zolpidem in improving catatonic schizophrenia. Case report].
    Hlal H; Kettani N; Berhili N; Rammouz I; Aalouane R
    Presse Med; 2014 Sep; 43(9):1018-20. PubMed ID: 24726030
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful treatment of tardive dystonia with clozapine.
    Adityanjee ; Estrera AB
    Biol Psychiatry; 1996 Jun; 39(12):1064-5. PubMed ID: 8780846
    [No Abstract]   [Full Text] [Related]  

  • 19. Clozapine for the treatment of psychosis in Parkinson's disease: chart review of 49 patients.
    Wagner ML; Defilippi JL; Menza MA; Sage JI
    J Neuropsychiatry Clin Neurosci; 1996; 8(3):276-80. PubMed ID: 8854298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine-induced hyperlipidemia resolved after switch to aripiprazole therapy.
    Ball MP; Hooper ET; Skipwith DF; Cates ME
    Ann Pharmacother; 2005 Sep; 39(9):1570-2. PubMed ID: 16046490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.